Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2016 | Can biosimilars ensure access to drugs for everyone?

Robin Foà • 9 Jun 2016
EHA 2016
General

Robin Foà, MD from the Sapienza University, Rome, Italy discusses whether biosimilars may help increase the access to novel drugs. Prof. Foà points out that the saving might be around 30% of the original drug cost, which means that biosimilars would not necessarily make novel drugs accessible everywhere. Biosimilars are a step forward but they will not solve the problem according to Prof. Foà.
Recorded at the European Hematology Association (EHA) 2016 Annual Congress in Copenhagen, Denmark.

More from Robin Foà

New frontiers in ALL - MRD for clinical practice
New frontiers in ALL - MRD for clinical practice
Robin Foà et al. • 29 Sep 2022
Novel treatment strategies in ALL
Novel treatment strategies in ALL
Nicholas Short et al. • 29 Sep 2022
Considerations for the implementation of novel therapies into ALL clinical practice
4:41
Considerations for the implementation of novel therapies into ALL clinical practice
Robin Foà • 15 Apr 2024
Are transplantation and chemotherapy still necessary for all patients with Ph+ ALL?
5:14
Are transplantation and chemotherapy still necessary for all patients with Ph+ ALL?
Robin Foà • 15 Apr 2024

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals